CLINICAL TRIALS PROFILE FOR BENAZEPRIL HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for BENAZEPRIL HYDROCHLORIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00136773 ↗ | Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus | Completed | Novartis | Phase 4 | 2003-04-01 | Type 2 diabetes mellitus is usually associated with high blood pressure, which is a risk factor for kidney disease. Aggressive blood pressure reduction is an important strategy to protect the kidney and reduce urinary protein which develops with kidney disease. This study will evaluate the effects of amlodipine/benazepril in reducing blood pressure and urinary protein in hypertensive subjects with type 2 diabetes mellitus. |
| NCT00136851 ↗ | Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension | Completed | Novartis Pharmaceuticals | Phase 4 | 2004-12-01 | This trial is designed to study the efficacy of an amlodipine besylate/benazepril treatment regimen versus an amlodipine treatment regimen in the treatment of severe hypertension. |
| NCT00139555 ↗ | Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension | Completed | Novartis | Phase 4 | 2004-07-01 | Left ventricular hypertrophy (LVH) increases the risk of cardiovascular morbidity and mortality in patients with high blood pressure, compared to those without LVH. Reduction of left ventricular mass (LVM) with antihypertensive agents is associated with improved clinical outcome. This study will evaluate the effects of amlodipine/benazepril in reducing LVM in patients with high risk hypertension. |
| NCT00170950 ↗ | Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension | Terminated | Novartis | Phase 3 | 2003-10-01 | A comparison study of two combination drugs, amlodipine/benazepril and benazepril/HCTZ to evaluate the effectiveness of the combination on reducing heart disease and death in a high risk hypertensive population. |
| NCT00171119 ↗ | A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril | Terminated | Novartis Pharmaceuticals | Phase 4 | 2004-01-01 | The purpose of this study is to evaluate the efficacy of valsartan, benazepril or the combination of both in reduction of microalbuminuria in Type 2 diabetic patients. |
| NCT00171366 ↗ | A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril. | Completed | Pfizer | Phase 3 | 2004-07-01 | Comparison of the safety and efficacy of the combination of amlodipine/Benazepril to amlodipine monotherapy in patients with non-essential hypertension, not controlled on amlodipine alone. |
| NCT00171366 ↗ | A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril. | Completed | Novartis | Phase 3 | 2004-07-01 | Comparison of the safety and efficacy of the combination of amlodipine/Benazepril to amlodipine monotherapy in patients with non-essential hypertension, not controlled on amlodipine alone. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BENAZEPRIL HYDROCHLORIDE
Condition Name
Clinical Trial Locations for BENAZEPRIL HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for BENAZEPRIL HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for BENAZEPRIL HYDROCHLORIDE
Sponsor Name
